Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50502 (
Hip
)
7,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hip
dysplasia is a common
congenital disorder
, and identified as a source of pain, functional impairment and increased risk for development of osteoarthritis. Early diagnosis and reference is essential in symptomatic hip dysplasia, since patients may be candidates for joint preserving surgery. Assessment concentrates on history, physical examination and plain radiography. If radiography confirms the diagnosis (CE-angle < 25 degrees), the patient should be referred for expert evaluation. The assessment of hip dysplasia should be well-known to GPs, orthopaedics and radiologists.
...
PMID:[Hip dysplasia: clinical assessment, radiologic evaluation and reference]. 1737 27
Congenital disease
of the hip (CDH) is a common reason for the development of secondary osteoarthritis at the hip joint and the need for total hip arthroplasty (THA). The distorted femoral anatomy in patients with CDH in combination with soft tissue considerations and leg length discrepancy complicate the procedure of THA and this sometimes precludes the implantation of classical industry designed femoral stems. In such cases a customised femoral implant must be used in order to optimise the fit of the stem to the femur, to improve strain distribution and to reconstruct hip biomechanics. The present study reviews the preoperative planning, the design and material selection of custom-made implants, the surgical techniques and the reported clinical results of the published literature on the use of custom-made femoral implants in patients with CDH.
Hip
Int 2016 May 16
PMID:Custom-made femoral implants in total hip arthroplasty due to congenital disease of the hip: a review. 2705 1